A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trial. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.4244/eij-d-23-00567
PubMed Identifier: 38214677
Publication URI: http://europepmc.org/abstract/MED/38214677
Type: Journal Article/Review
Volume: 20
Parent Publication: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Issue: 3
ISSN: 1774-024X